Simply Wall St.
Has Ionis Pharmaceuticals Run Too Far After 135% Surge and Bullish DCF Outlook?
📊
AI Sentiment
Positive
7/10
Ionis Pharmaceuticals Inc. News
Latest updates and market news for IONS
2 news
Dec 5 - Dec 11, 2025
Page 1
Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting
📈
AI Sentiment
Highly Positive
8/10
Share this news page